US Patent Issued to CYCLOLAB CYCLODEXTRIN RESEARCH AND DEVELOPMENT LABORATORY on July 21 for "Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases" (Hungarian Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,746, issued on July 21, was assigned to CYCLOLAB CYCLODEXTRIN RESEARCH AND DEVELOPMENT LABORATORY LTD. (Budapest, Hungary).

"Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases" was invented by Istvan Puskas (Budapest, Hungary) and Abdula Kurkayev (Budapest, Hungary).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention generally relates to use of single isomer chemically modified cyclodextrins, namely, S-(carboxyalkyl)-thio-cyclodextrin salts in medication used for the prevention or treatment of lysosomal storage diseases. More particularly, the present invention relates to isomer-pure, sing...